Additive manufacturing, commonly referred to as Pharmaceutics 3D Printing, has become a ground-breaking technology with significant ramifications for the pharmaceutical industry. Pharmaceutics 3D Printing has the potential to revolutionize pharmaceutical manufacturing and patient care by making it possible to precisely fabricate intricate drug delivery systems and tailored therapeutics. This overview explores the fundamentals, methods, supplies, and uses of Pharmaceutics 3D Printing in the pharmaceutical industry. It also examines the difficulties and potential applications of this technology, emphasizing how it can improve drug administration and individualized treatment plans. These restrictions may be overcome by three-dimensional (3D) printing technology, which can be used to quickly create customized tissue, fix tissue flaws in situ using cells, and even print organs and tissue directly. By adding materials one after the other, digital fabrication technology—also known as additive manufacturing or Pharmaceutics 3D Printing—makes tangible items from geometric representations. It is expanding quickly and is employed in a variety of fields, including the defense and aviation industries. Pharmaceutics 3D Printing's applications in surgery, the pharmaceutical industry, disease modeling, the creation of personalized implants and prostheses, organ printing, veterinary medicine, and tissue engineering have all been described. This new technique is contrasted with more conventional approaches in the biomedical field.
No takes yet. Share an insight, caveat, or question.
Bachhav et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: